Summary Keywords antioxidant, bronchiectasis, COPD, cystic fibrosis, mucolytic, N-acetylcysteine Citation Barne M, Shevade M, Bhattacharyya P, Christopher DJ, Nair S, Abhyankar N, Halder I, Vora A, Khanna A, Swarnakar R, Chhajed P, Santhalingam B, Nair A and Salvi S (2026) N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR)
CONFLICT OF INTEREST The author of this work declares that she has no conflicts of interest
Changes in the performance of these proteins have a direct effect on how the drug is absorbed, distributed, metabolized, and eliminated (Nies et al., 2008)
KWONG: Yeah, you said earlier that injectables can be over $1,000 a month, certainly a few hundred dollars a month depending on your situation
Nirmatrelvir Plus Ritonavir: First Approval [published correction appears in Drugs
Even those who are afraid of needles need not worry